| First Author | Krogsdam AM | Year | 2002 |
| Journal | Biochem J | Volume | 363 |
| Issue | Pt 1 | Pages | 157-65 |
| PubMed ID | 11903058 | Mgi Jnum | J:75865 |
| Mgi Id | MGI:2177976 | Doi | 10.1042/0264-6021:3630157 |
| Citation | Krogsdam AM, et al. (2002) Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation. Biochem J 363(Pt 1):157-65 |
| abstractText | The nuclear receptor corepressor (NCoR) was isolated as a peroxisome-proliferator-activated receptor (PPAR) delta interacting protein using the yeast two-hybrid system. NCoR interacted strongly with the ligand-binding domain of PPARdelta, whereas interactions with the ligand-binding domains of PPARgamma and PPARalpha were significantly weaker. PPAR-NCoR interactions were antagonized by ligands in the two-hybrid system, but were ligand-insensitive in in vitro pull-down assays. Interaction between PPARdelta and NCoR was unaffected by coexpression of retinoid X receptor (RXR) alpha. The PPARdelta-RXRalpha heterodimer bound to an acyl-CoA oxidase (ACO)-type peroxisome-proliferator response element recruited a glutathione S-transferase-NCoR fusion protein in a ligand-independent manner. Contrasting with most other nuclear receptors, PPARdelta was found to interact equally well with interaction domains I and II of NCoR. In transient transfection experiments, NCoR and the related silencing mediator for retinoid and thyroid hormone receptor (SMRT) were shown to exert a marked dose-dependent repression of ligand-induced PPARdelta-mediated transactivation; in addition, transactivation induced by the cAMP-elevating agent forskolin was efficiently reduced to basal levels by NCoR as well as SMRT coexpression. Our results suggest that the transactivation potential of liganded PPARdelta can be fine-tuned by interaction with NCoR and SMRT in a manner determined by the expression levels of corepressors and coactivators. |
